Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 10, 2026

Azul 2026 State of Java Survey & Report: 62% of Enterprises Now Leverage Java to Power AI Functionality, 41% Rely on High-Performance Java Platforms to Reduce Cloud Compute Costs

View original at finance.yahoo.com
Azul 2026 State of Java Survey & Report: 62% of Enterprises Now Leverage Java to Power AI Functionality, 41% Rely on High-Performance Java Platforms to Reduce Cloud Compute Costs Azul's 2026 State of Java Survey & Report's key metrics Survey of over 2,000 Java professionals also reveals: 92% are concerned about Oracle…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 31% of respondents say more than half of the Java applications they build now contain AI functionality

    80% confidence
  • 63% of respondents say that dead and unused code affects their team's productivity, while only 6% report no impact at all

    80% confidence
  • 56% of enterprises now deal with Java-related CVEs on a daily or weekly basis, a sharp rise from 41% in 2025

    80% confidence
  • 41% of enterprises use a high-performance Java platform as one of the top five strategies to reduce public cloud costs

    80% confidence
  • Top capabilities important for Java to remain competitive in AI-enabled development include long-term support for modern Java versions (35%), built-in security features (34%), observability insights (32%), support for large data access (30%), and integration with large language models (30%)

    80% confidence
  • 81% have migrated, are migrating, or plan to migrate at least part of their Oracle Java to a non-Oracle OpenJDK distribution

    80% confidence
  • Java continues to prove its durability and strategic importance as enterprises navigate one of the most transformative periods in modern computing

    80% confidence
  • 97% of survey participants have taken actions to reduce their public cloud costs

    80% confidence
  • 21% of survey respondents have already been subjected to an Oracle Java audit

    80% confidence
  • 74% of organizations report more than 20% unused compute capacity in their public cloud environments

    80% confidence
  • Among enterprises where at least 90% of applications run on Java, 81% use a high-performance Java platform to improve application performance (compared to 61% overall)

    80% confidence
  • 30% of survey respondents said their teams waste more than half their time chasing false positives in security scans

    80% confidence
  • Java remains at the center of innovation and operational excellence, with the community evolving quickly, embracing open technologies, accelerating cloud optimization and removing DevOps friction

    80% confidence
  • 63% intend to migrate their entire Java estate from Oracle Java

    80% confidence
  • 62% of organizations now use Java to code AI functionality, up from 50% last year

    80% confidence
  • Cost remains the number one driver (37%) for migrating away from Oracle

    80% confidence
  • 92% of respondents report being concerned about Oracle's pricing, while only 7% say they are not at all concerned

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Azul 2026 State of Java Survey & Report: 62% of Enterprises Now Leverage Java to Power AI Functionality, 41% Rely on High-Performance Java Platforms to Reduce Cloud Compute Costs — Source | Via News | Via News